Temporal quantitative phosphoproteomics of human platelets reveals rapid, inverse regulation of specific signaling hubs by ADP and Iloprost, identifying potential novel targets for antiplatelet therapy.
No takes yet. Share an insight, caveat, or question.
May identify novel antiplatelet targets in platelet signaling; leaves open clinical translation pending in vivo validation.
Beck et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: